Jenner & Block

“Key Developments in Biosimilar Litigation,” Jenner & Block

Jenner & Block Partners Louis E. Fogel, Paul D. Margolis and Steven R. Trybus will speak at a webinar sponsored by Jenner & Block. Titled  “Key Developments in Biosimilar Litigation,” this webinar will discuss the market for biosimilars and explore issues being considered by both innovators and companies who plan to bring biosimilars to the U.S. market.  The program will explore arguments being made and considered in interpreting the Biologics Price Competition and Innovation Act (BPCIA), including a discussion of the key rulings, pending motions and arguments in the Amgen v. Sandoz cases relating to the BPCIA.  The webinar will be held from noon to 1 pm CST on March 11, 2015.

Mr. Fogel counsels life sciences clients in all aspects of complex patent litigation to help businesses achieve their strategic goals. He has litigated across a range of technologies, including biotechnology, pharmaceuticals, medical devices, and consumer electronics. He is also an experienced trial lawyer with courtroom experience before both juries and in bench proceedings.

Mr. Margolis is a litigator who focuses on intellectual property.  Clients seek his help with patent infringement actions in a wide range of scientific fields, including chemical, pharmaceutical, biomedical, electronics, mechanical and agricultural.

Mr. Trybus concentrates on patent infringement litigation in court and in PTAB proceedings.  He is experienced in a variety of technologies including pharmaceuticals and medical devices to electronics, software, mechanical devices and polymers,

To RSVP, please click here.